Cargando…

Combination therapy for inflammatory bowel disease

Biologic therapies such as infliximab and adalimumab have become mainstays of treatment for inflammatory bowel disease. Early studies suggested that combination therapy (CT) with infliximab and an immunomodulator drug such as azathioprine may help optimize biologic pharmacokinetics, minimize immunog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sultan, Keith S, Berkowitz, Joshua C, Khan, Sundas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421108/ https://www.ncbi.nlm.nih.gov/pubmed/28533919 http://dx.doi.org/10.4292/wjgpt.v8.i2.103

Ejemplares similares

Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
por: Berkowitz, Joshua C, et al.
Publicado: (2018)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
por: Balderramo, Domingo
Publicado: (2022)

Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease
por: Dailey, Francis E, et al.
Publicado: (2018)

Inflammatory bowel disease and airway diseases
por: Vutcovici, Maria, et al.
Publicado: (2016)

Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
por: McCormack, Matthew D, et al.
Publicado: (2023)

Effect of inflammatory bowel disease treatments on patients with diabetes mellitus
por: Bower, Joshua Ashley Jack, et al.
Publicado: (2021)

Pregnancy and medications for inflammatory bowel disease: An updated narrative review
por: Akiyama, Shintaro, et al.
Publicado: (2023)

Biosimilars in paediatric inflammatory bowel disease
por: Sieczkowska-Golub, Joanna, et al.
Publicado: (2018)

Food as Treatment of Inflammatory Bowel Diseases
por: Maldonado-Contreras, Ana
Publicado: (2022)

Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
por: Dubois-Camacho, Karen, et al.
Publicado: (2017)

Analysis of the clinical indications for opiate use in inflammatory bowel disease
por: Gao, Youran, et al.
Publicado: (2017)

Evolving roles of magnifying endoscopy and endoscopic resection for neoplasia in inflammatory bowel diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Necroptosis in inflammatory bowel disease and other intestinal diseases
por: Li, Sha, et al.
Publicado: (2018)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Enteroscopy in children and adults with inflammatory bowel disease
por: Di Nardo, Giovanni, et al.
Publicado: (2020)

Proteomic insights on the metabolism in inflammatory bowel disease
por: Pisani, Laura Francesca, et al.
Publicado: (2020)

Role of diet and nutrition in inflammatory bowel disease
por: de Castro, Marina Moreira, et al.
Publicado: (2021)

Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology
por: Malinauskiene, Vaidota, et al.
Publicado: (2023)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Potential role of nutraceutical compounds in inflammatory bowel disease
por: Larussa, Tiziana, et al.
Publicado: (2017)

Sexual health and fertility for individuals with inflammatory bowel disease
por: Leenhardt, Romain, et al.
Publicado: (2019)

Emerging use of artificial intelligence in inflammatory bowel disease
por: Kohli, Arushi, et al.
Publicado: (2020)

Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021)

Novel drug delivery systems for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Application of single-cell omics in inflammatory bowel disease
por: Zheng, Hengqi Betty
Publicado: (2023)

Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment
por: Actis, Giovanni C, et al.
Publicado: (2017)

Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease
por: Shukla, Richa, et al.
Publicado: (2017)

Treating children with inflammatory bowel disease: Current and new perspectives
por: Guariso, Graziella, et al.
Publicado: (2017)

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
por: Wang, Alice Yuxin, et al.
Publicado: (2016)

Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment
por: Spiceland, Clayton M, et al.
Publicado: (2018)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Liver manifestations and complications in inflammatory bowel disease: A review
por: Gaspar, Rui, et al.
Publicado: (2021)

Shared decision-making in the management of patients with inflammatory bowel disease
por: Song, Kai, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7dtcueg8068iarfntgjue3t4pa